English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Significance Pandemic influenza continues to threaten public health across the world. Cross-species transmission of avian H5N1, H7N9, and H10N8 subtypes represent a potential threat to human as the viruses may acquire the ability to pass efficiently from human to human. In order to develop an effective influenza vaccine with protective immunity against a broad range of human and avian influenza viruses, we generated a monoglycosylated consensus cHA (cHAmg ) from human H1N1 and avian H5N1 HAs. After immunization with the monoglycosylated consensus cHA vaccine, mice were found to generate a high level of antibodies with broader cross-reactive neutralizing activities, higher ADCC responses, and more memory CD8+ T cell response. This strategy may facilitate the development of a universal vaccine against influenza viruses.

Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes